Skip to content

Anatara Lifesciences Ltd Sustainability Reports

Anatara Lifesciences Ltd focuses on developing and commercializing innovative, evidence-based oral solutions for gastrointestinal diseases in humans and animals. Its research mainly targets complex gastrointestinal tract conditions and non-antibiotic treatments like dietary supplements.

Sector: Manufacturing

Country: Australia

Exchange: Australian Securities Exchange

FIGI: BBG0077TH9J5

6 reports from 2015 to 2023